Comparative Analysis of Social Cognitive and Neurocognitive Performance Across Autism and Schizophrenia Spectrum Disorders
- PMID: 40036301
- PMCID: PMC12809814
- DOI: 10.1093/schbul/sbaf005
Comparative Analysis of Social Cognitive and Neurocognitive Performance Across Autism and Schizophrenia Spectrum Disorders
Abstract
Background and hypothesis: Social cognitive and neurocognitive performance is impacted in autism and schizophrenia spectrum disorders (SSDs). Here, we compared social cognitive and neurocognitive performance across a large transdiagnostic sample of participants with autism, SSDs, and typically developing controls (TDCs).
Study design: Participants (total N = 584; autism N = 100, SSDs N = 275, TDCs N = 209; aged 16-55 years; 61% male assigned at birth) completed lower-level (eg, emotion processing) and higher-level (eg, theory of mind) social cognitive tasks, the MATRICS Consensus Cognitive Battery, and a measure of social functioning. Nonparametric groupwise comparisons were undertaken, adjusting for age and sex, and within-group correlations were used to examine associations between social cognition, neurocognition, and social functioning.
Study results: Autistic and SSD groups performed worse than TDCs on lower- and higher-level social cognitive tasks, with few autism-SSD differences found. Autism and SSDs had lower neurocognitive scores than TDCs; SSDs demonstrated lower processing speed, working memory, verbal learning, and visual learning versus autism. Positive associations between social cognitive tasks and neurocognition were observed across groups, and self-reported measures of empathy were consistently correlated with social functioning.
Conclusions: This study represents the largest transdiagnostic comparison of both social cognition and neurocognition in an autism/SSD sample reported to date. Autistic participants and those with SSDs showed similar performance on lower- and higher-level social cognitive tasks relative to controls, while neurocognition was less impacted in autism versus SSDs. These findings underscore the importance of transdiagnostic research into the mechanisms underlying social cognitive deficits and highlight the potential for developing transdiagnostic interventions.
Keywords: autism spectrum disorder; neurocognition; schizophrenia spectrum disorder; social cognition; social functioning.
© The Author(s) 2025. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center.
Conflict of interest statement
The authors have no relevant financial relationships or other conflicts of interest to disclose. L.D.O. receives grant support from the Brain & Behavior Research Foundation (BBRF). I.M.-E. was supported by the Labatt Family Network for Research on the Biology of Depression. C.H. receives grant support from the National Institute of Mental Health (NIMH), Canadian Institutes of Health Research (CIHR), and the Centre for Addiction and Mental Health (CAMH) Foundation. E.W.D. has received funding from BBRF, NIMH, CIHR, and CAMH Foundation. J.-C.Y. receives grant support from the Discovery Fund of the Centre for Addiction and Mental Health (CAMH). P.S. is supported by CIHR, the Academic Scholars award from the Department of Psychiatry, University of Toronto, and receives royalties from Guilford Press and Simon & Schuster. P.D. is currently supported by CIHR, CAMH Discovery Fund Seed Funding, Innovation Fund of the Alternative Funding Plan for the Academic Health Sciences Centres of Ontario, and Academic Scholar Award from Department of Psychiatry, University of Toronto. R.W.B. has consulted for Boehringer-Ingelheim, serves on the Data Safety and Monitoring Boards of Roche, Merck, and Newron, and has served on the Advisory Boards of Merck, Acadia, Karuna, and Neurocrine. A.K.M. receives grant support from the NIMH (R01 MH109508, R01 MH108654, R61 MH120188). M.-C.L. receives funding from the CIHR (PJT-173351, PJT-180620, GSB-171373), the Academic Scholars Award from the Department of Psychiatry, University of Toronto, and CAMH Foundation. A.N.V. currently receives funding from the NIMH (1/3R01 MH102324, 1/5R01 MH114970), CIHR, Canada Foundation for Innovation, CAMH Foundation, and University of Toronto. S.H.A. currently receives funding from the NIMH (R01 MH114879), CIHR, the Canada Research Chairs Program, University of Toronto, and the CAMH Foundation.
Figures
References
-
- Pichot P. DSM-III: The 3rd edition of the Diagnostic and Statistical Manual of Mental Disorders from the American Psychiatric Association. Rev Neurol (Paris). 1986;142:489–499. - PubMed
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association; 2013.
-
- Schalbroeck R, Foss-Feig JH, Jutla A, Ziermans TB. Integrating neuropsychological research on autism and psychosis to improve clinical outcomes. Nat Rev Psychol. 2023;2:723–739.
